Global Laboratory-developed Testing Market Rising Trend | Adaptive Biotechnologies Corporation, Biotheranostics, Illumina – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Posted on 322
Previon™, the leader in providing at-home patient testing kits, healthcare screening and patient engagement communications, announced it has partnered with Spectrum Solutions™, manufacturer of the first FDA EUA-authorized saliva collection kit for COVID-19 testing. The companies will collaborate to aid any organization in delivering at-home COVID-19 test kits throughout the United States. Previon will begin shipping kits in early February 2021 from its state-of-the-art fulfillment center, satisfying overflow production for Spectrum Solutions wide range of clients.
“Getting tests to essential workers who may need to be tested often is vital, as COVID-19 continues to surge,” said Joel Luce, CEO of Previon. “Our partnership with Spectrum Solutions makes Previon the only company with an ‘under-one-roof’ capability to manage large scale, at-home test fulfillment, from design to production for COVI
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
Friday, January 15, 2021
The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa.
Eurofins is pleased to announce the following initiatives to support health authorities variant detection and monitoring programmes:
Increasing, to more than 5,000 full genomes per day, the capacity for its ARTIC Next Generation Sequencing (NGS)